Qube Research & Technologies Ltd ACN — ACCENTURE PLC IRELAND

Ownership history in Qube Research & Technologies Ltd  ·  43 quarters on record

AI Ownership Summary

Qube Research & Technologies Ltd reported ACCENTURE PLC IRELAND (ACN) in 43 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 0.76% in 2024 Q2. The latest visible filing shows ACN at 0.06% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this ACN ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Qube Research & Technologies Ltd's position in ACCENTURE PLC IRELAND, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

ACN was reported at 0.06% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.76% in 2024 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

ACN stock page Qube Research & Technologies Ltd fund profile Qube Research & Technologies Ltd full holdings
How Qube Research & Technologies Ltd held ACN — position size vs. price
% of Fund (quarterly)    ACN price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 27 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED 22.9% -26.1% ✅ 208,700 -61,900 -22.9% 0.06% $56.0M 2026-02-14 (Est.) $222.34
2025 Q4 REDUCED 42.1% -26.1% ✅ 270,600 -197,040 -42.1% 0.07% $72.6M 2026-02-14 (Est.) $222.34
2025 Q4 ADDED — — — 467,640 +325,440 +228.9% 0.13% $125.5M 2026-02-14 (Est.) $222.34
2025 Q3 REDUCED 30.4% +10.0% ❌ 142,200 -62,000 -30.4% 0.04% $35.1M 2025-11-14 $243.15
2025 Q3 REDUCED 88.2% +10.0% ❌ 204,200 -1,529,793 -88.2% 0.05% $50.4M 2025-11-14 $243.15
2025 Q3 ADDED — — — 1,733,993 +1,595,293 +1150.2% 0.44% $427.6M 2025-11-14 $243.15
2025 Q2 REDUCED 79.2% -16.9% ✅ 138,700 -529,690 -79.2% 0.04% $41.5M 2025-08-14 $244.09
2025 Q2 ADDED — — — 668,390 +503,890 +306.3% 0.20% $199.8M 2025-08-14 $244.09
2025 Q2 ADDED — — — 164,500 +118,000 +253.8% 0.05% $49.2M 2025-08-14 $244.09
2025 Q1 ADDED — — — 46,500 +41,600 +849.0% 0.02% $14.5M 2025-05-15 $318.90
2025 Q1 REDUCED 96.5% -3.7% ✅ 4,900 -136,662 -96.5% 0.00% $1.5M 2025-05-15 $318.90
2025 Q1 ADDED — — — 141,562 +32,373 +29.6% 0.05% $44.2M 2025-05-15 $318.90
2024 Q4 REDUCED 9.8% -10.9% ✅ 109,189 -11,811 -9.8% 0.05% $38.4M 2025-02-14 $380.93
2024 Q4 ADDED — — — 121,000 +112,900 +1393.8% 0.06% $42.6M 2025-02-14 $380.93
2024 Q4 REDUCED 80.0% -10.9% ✅ 8,100 -32,500 -80.0% 0.00% $2.8M 2025-02-14 $380.93
2024 Q3 REDUCED 76.0% +0.1% ❌ 40,600 -128,500 -76.0% 0.02% $14.4M 2024-11-14 $353.97
2024 Q3 REDUCED 25.3% +0.1% ❌ 169,100 -57,365 -25.3% 0.09% $59.8M 2024-11-14 $353.97
2024 Q3 REDUCED 85.8% +0.1% ❌ 226,465 -1,363,441 -85.8% 0.12% $80.1M 2024-11-14 $353.97
2024 Q2 ADDED — — — 1,589,906 +1,584,306 +28291.2% 0.76% $482.4M 2024-08-14 $311.41
2024 Q2 REDUCED 96.6% +17.0% ❌ 5,600 -160,800 -96.6% 0.00% $1.7M 2024-08-14 $311.41
2024 Q2 REDUCED — — — 166,400 -4,661 -2.7% 0.08% $50.5M 2024-08-14 $311.41
2024 Q1 ADDED — — — 171,061 +164,261 +2415.6% 0.09% $59.3M 2024-05-14 $297.56
2024 Q1 REDUCED 95.8% -12.4% ✅ 6,800 -154,200 -95.8% 0.00% $2.4M 2024-05-14 $297.56
2024 Q1 ADDED — — — 161,000 +104,300 +184.0% 0.09% $55.8M 2024-05-14 $297.56
2023 Q4 ADDED — — — 56,700 +55,700 +5570.0% 0.04% $19.9M 2024-02-13 $350.36
2023 Q4 REDUCED 99.8% -3.0% ✅ 1,000 -526,733 -99.8% 0.00% $351K 2024-02-13 $350.36
2023 Q4 ADDED — — — 527,733 +511,533 +3157.6% 0.36% $185.2M 2024-02-13 $350.36
16 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding ACN

As of 2026 Q1 — sorted by position size

Fairman Group, LLC 14.8% Hummer Financial Advisory Services Inc 3Y 7.14% PROVIDENT TRUST CO 3Y 7Y 5.53% Banque de Luxembourg S.A. 4.46% Seilern Investment Management Ltd 4.09% Value Partners Investments Inc. 3Y 3.91% GUARDCAP ASSET MANAGEMENT Ltd 3Y 7Y 3.9% LETSON INVESTMENT MANAGEMENT, INC. 3.33% Guild Investment Management, Inc. 3Y 7Y 3.26% Asset Management Advisors, LLC 3Y 7Y 3.16%

FAQ About Qube Research & Technologies Ltd and ACN

These are the practical questions this page is built to answer before you even open the full history table.

How long has Qube Research & Technologies Ltd reported owning ACN?

Qube Research & Technologies Ltd reported ACN across 27 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported ACN position in Qube Research & Technologies Ltd's portfolio?

The largest reported portfolio weight for ACN was 0.76% in 2024 Q2.

What is the latest reported ACN position on this page?

The most recent filing on this page is 2025 Q4, when Qube Research & Technologies Ltd reported 208,700 shares, equal to 0.06% of portfolio, with an estimated market value of $56.0M.

What does the chart on this ACN ownership page compare?

The chart compares Qube Research & Technologies Ltd's quarterly ACN portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Qube Research & Technologies Ltd time their ACN position?

Based on 13F filing dates vs. subsequent ACN price moves, Qube Research & Technologies Ltd correctly timed 23 out of 42 reported position changes (55%). The annualised alpha on ACN relative to SPY over the holding period was -8.7%.

← Back to Qube Research & Technologies Ltd Holdings